In 2023, Japan's government expenditure on R&D in medical and health sciences stood at approximately 2.1 billion US dollars PPP. The forecast data indicates a consistent year-on-year growth: 5.9% in 2025, 5.5% in 2026, 4.8% in 2027, and 4.6% in 2028. The average compound annual growth rate (CAGR) from 2024 to 2028 is projected to be around 5.2%, reflecting a steady upward trend in investment.

Future trends to watch for include:

Increased emphasis on digital health technologies and AI-driven R&D.
Potential policy shifts to enhance public-private partnerships in health sciences.
Growing awareness and investment in global health challenges and pandemic preparedness.